BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20/05/2005

FDA Clears ZITHROMAX 250mg Oral Capsules for Approval

The FDA has ruled that ZITHROMAX (azithromycin) 250mg oral capsules were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →